Jump to main content
Jump to site search


Thiosemicarbazone-based selective proliferation inactivators inhibit gastric cancer cell growth, invasion, and migration

Author affiliations

Abstract

A series of novel thiosemicarbazone derivatives were synthesized and evaluated for their antiproliferative activity against several selected tumor cell lines of different origins using the MTT assay. The preliminary results indicated that the MGC-803 cell line was remarkably sensitive to all the synthesized compounds. Among this series, compound 5n showed the best inhibitory activity with an IC50 value of 0.93 μM (about 10-fold more potent than 3-AP) against MGC-803. Further mechanism studies revealed that compound 5n could obviously inhibit the proliferation of MGC-803 cells by inducing apoptosis and arresting the cell cycle at the S phase. Compound 5n also showed marked inhibition of cell migration and invasion, without significant cytotoxicity against gastric epithelial immortalized GES-1 cells.

Graphical abstract: Thiosemicarbazone-based selective proliferation inactivators inhibit gastric cancer cell growth, invasion, and migration

Back to tab navigation

Supplementary files

Publication details

The article was received on 14 Jul 2017, accepted on 19 Sep 2017 and first published on 23 Oct 2017


Article type: Research Article
DOI: 10.1039/C7MD00353F
Citation: Med. Chem. Commun., 2017, Advance Article
  •   Request permissions

    Thiosemicarbazone-based selective proliferation inactivators inhibit gastric cancer cell growth, invasion, and migration

    B. Hu, B. Wang, B. Zhao, Q. Guo, Z. Li, X. Zhang, G. Liu, Y. Liu, Y. Tang, F. Luo, Y. Du, Y. Chen, L. Ma and H. Liu, Med. Chem. Commun., 2017, Advance Article , DOI: 10.1039/C7MD00353F

Search articles by author

Spotlight

Advertisements